v3.23.3
Condensed Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net loss $ (7,366,758) $ (6,071,556)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of discount on convertible notes 159,262
Change in carrying value of right-of-use asset 141,108 133,605
Stock-based compensation expense 975,422 541,333
Loss on debt extinguishment 2,261,581
Changes in operating assets and liabilities, net:    
Accrued interest on marketable debt securities (110,937)
Prepaid expenses (908,315) 32,384
Other current assets 61,169 2,353
Other assets 139,300
Accounts payable (244,772) 623,797
Accrued expenses (1,368,394) 986,189
Accrued interest on convertible note 145,899 44,877
Change in lease liabilities (142,398) (135,645)
Net cash used in operating activities (6,257,833) (3,842,663)
Cash flows from investing activities:    
Purchase of marketable debt securities (8,844,379)
Net cash used in investing activities (8,844,379)
Cash flows from financing activities:    
Proceeds from issuance of convertible note 242,552
Payout of fractional shares on reverse split (44)
Proceeds from Initial Public Offering 19,500,000
Proceeds from overallotment shares 2,925,000
Issuance costs related to initial public offering and overallotment (2,233,348)
Proceeds from exercise of options and warrants 50,000
Net cash provided by financing activities 20,484,160
Net increase (decrease) in cash and cash equivalents 5,381,948 (3,842,663)
Cash and cash equivalents at beginning of period 1,311,877 4,539,229
Cash and cash equivalents at end of period 6,693,825 696,566
Supplemental disclosure of non-cash financing activities:    
Right-of-use lease asset and operating lease liability 154,624
Conversion of convertible notes and accrued interest into common stock 4,736,999
Warrants issued in relation to issuance of convertible notes 159,262  
Warrants issued to underwriter in connection with stock issuance 1,169,719
Preferred stock deemed dividend $ 1,323,535

Source